Genesis Minerals Limited reported a record December quarter gold production of 57,055oz, driven by an accelerated Laverton mill restart and strong operational execution. The company’s cash reserves surged 34% to A$238 million, underpinning its debt-free growth strategy.
Orthocell Limited has reported a third consecutive quarter of record revenue, driven by strong sales growth and strategic market expansions, including a key US FDA submission for its nerve repair product Remplir™.